Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Ingelman-Sundberg

Showing results (31-40 of 284) with videos related to

Pageof 29
Sort By:
Biochemical and Biophysical Research Communications|May 25, 2010
Pharmacogenetic biomarkers as tools for improved drug therapy; emphasis on the cytochrome P450 systemMagnus Ingelman-Sundberg, Sarah C Sim
Basic & Clinical Pharmacology & Toxicology|April 19, 2021
3D human liver spheroids for translational pharmacology and toxicologyMagnus Ingelman-Sundberg, Volker M Lauschke
Pharmacogenomics|June 2, 2016
Requirements for comprehensive pharmacogenetic genotyping platformsVolker M Lauschke, Magnus Ingelman-Sundberg
International Journal of Molecular Sciences|October 19, 2016
The Importance of Patient-Specific Factors for Hepatic Drug Response and ToxicityVolker M Lauschke, Magnus Ingelman-Sundberg
Pharmacological Reviews|March 10, 2026
The evolving landscape of pharmacogenomics: Current achievements and future directionsVolker M Lauschke, Magnus Ingelman-Sundberg
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 21, 2024
Rare variants and clozapine: ReplyRoos van Westrhenen, Magnus Ingelman-Sundberg
Human Genomics|September 18, 2010
Intronic polymorphisms of cytochromes P450Magnus Ingelman-Sundberg, Sarah C Sim
Trends in Pharmacological Sciences|December 28, 2010
Pharmacogenomic biomarkers: new tools in current and future drug therapySarah C Sim, Magnus Ingelman-Sundberg
Methods in Molecular Biology (Clifton, N.J.)|October 5, 2016
The Human Cytochrome P450 Allele Nomenclature Committee Web Site : Submission Criteria, Procedures, and ObjectivesSarah C Sim, Magnus Ingelman-Sundberg
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 13, 2005
Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapyMagnus Ingelman-Sundberg, Cristina Rodriguez-Antona
Pageof 29

Showing results (31-40 of 284) with videos related to

Sort By:
Pageof 29
Biochemical and Biophysical Research Communications|May 25, 2010
Pharmacogenetic biomarkers as tools for improved drug therapy; emphasis on the cytochrome P450 systemMagnus Ingelman-Sundberg, Sarah C Sim
Basic & Clinical Pharmacology & Toxicology|April 19, 2021
3D human liver spheroids for translational pharmacology and toxicologyMagnus Ingelman-Sundberg, Volker M Lauschke
Pharmacogenomics|June 2, 2016
Requirements for comprehensive pharmacogenetic genotyping platformsVolker M Lauschke, Magnus Ingelman-Sundberg
International Journal of Molecular Sciences|October 19, 2016
The Importance of Patient-Specific Factors for Hepatic Drug Response and ToxicityVolker M Lauschke, Magnus Ingelman-Sundberg
Pharmacological Reviews|March 10, 2026
The evolving landscape of pharmacogenomics: Current achievements and future directionsVolker M Lauschke, Magnus Ingelman-Sundberg
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 21, 2024
Rare variants and clozapine: ReplyRoos van Westrhenen, Magnus Ingelman-Sundberg
Human Genomics|September 18, 2010
Intronic polymorphisms of cytochromes P450Magnus Ingelman-Sundberg, Sarah C Sim
Trends in Pharmacological Sciences|December 28, 2010
Pharmacogenomic biomarkers: new tools in current and future drug therapySarah C Sim, Magnus Ingelman-Sundberg
Methods in Molecular Biology (Clifton, N.J.)|October 5, 2016
The Human Cytochrome P450 Allele Nomenclature Committee Web Site : Submission Criteria, Procedures, and ObjectivesSarah C Sim, Magnus Ingelman-Sundberg
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 13, 2005
Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapyMagnus Ingelman-Sundberg, Cristina Rodriguez-Antona
Pageof 29